Gilead Sciences, Inc.
INTEGRASE INHIBITORS FOR THE PREVENTION OF HIV
Last updated:
Abstract:
The present invention provides methods of preventing HIV in a subject, comprising administering to the subject a therapeutically effective amount of bictegravir, or a pharmaceutically acceptable salt thereof, optionally in combination with one or more additional therapeutic agents. Methods of reducing the risk of acquiring HIV (e.g., HIV-1 and/or HIV-2) are also provided.
Status:
Application
Type:
Utility
Filling date:
18 Sep 2019
Issue date:
23 Dec 2021